You are here: Industry Insights > acquisition

News List

Novo Nordisk to acquire Corvidia Therapeutics for $725m pharmaceutical-technology
June 15, 2020
Danish healthcare company Novo Nordisk has signed a definitive agreement to acquire US-based Corvidia Therapeutics, which develops and commercialises therapies for cardio-renal diseases, for an upfront payment of $725m.
Dr Reddy’s Laboratories completes acquisition of Wockhardt’s select business divisions expresspharma
June 11, 2020
The acquired divisions comprise a portfolio of 62 brands in multiple therapy areas such as respiratory, neurology, VMS, dermatology, gastroenterology, pain and vaccines.
Cipla acquires stake in GoApptiv expresspharma
June 10, 2020
The acquisition of 21.85 per cent stake on a fully diluted basis will be completed in two stages.
Ajinomoto Bio-Pharma Completes Acquisition of Granules OmniChem Joint Venture in India americanpharmaceuticalreview
June 03, 2020
Ajinomoto Bio-Pharma Services has completed the acquisition of Granules OmniChem Private Limited, purchasing the remaining 50 percent ownership interest from its joint venture partner, Granules India Limited.
Boehringer Ingelheim acquires Northern Biologics’ preclinical cancer antibody pipeline expresspharma
May 18, 2020
The acquisition provides assets targeting tumour stroma and myeloid cells.
AbbVie completes acquisition of Allergan expresspharma
May 14, 2020
The transaction significantly expands and diversifies AbbVie’s revenue base and complements existing leadership positions in immunology.
FTC accepts proposal for to AbbVie acquire Allergan for $63 billion europeanpharmaceuticalreview
May 12, 2020
AbbVie and Allergan have announced the Federal Trade Commission has accepted AbbVie’s pending acquisition of Allergan for $63 billion.
The Carlyle Group to acquire majority stake in SeQuent Scientific expresspharma
May 11, 2020
The transaction is expected to close in the third quarter of 2020, subject to customary closing conditions and regulatory approvals.
Sartorius Closes Acquisition of Danaher Life Sciences Selected Assets americanpharmaceuticalreview
May 07, 2020
Sartorius has closed the acquisition of selected life science businesses of Danaher Corporation. The transaction was completed on April 30, 2020, after receiving the required regulatory approvals.
Adare Pharma Acquires Orbis Biosciences contractpharma
May 07, 2020
Expands Adare’s technology platforms and product development capabilities.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 40 41 Next page